help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taniguchi, F.
Right arrow Articles by Terakawa, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taniguchi, F.
Right arrow Articles by Terakawa, N.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 2 773-780
Copyright © 2003 by The Endocrine Society

Activation of Mitogen-Activated Protein Kinase Pathway by Keratinocyte Growth Factor or Fibroblast Growth Factor-10 Promotes Cell Proliferation in Human Endometrial Carcinoma Cells

Fuminori Taniguchi, Tasuku Harada, Yasuko Sakamoto, Nobuhiro Yamauchi, Souichi Yoshida, Tomio Iwabe and Naoki Terakawa

Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago 683-8504, Japan

Address all correspondence and requests for reprints to: Fuminori Taniguchi, M.D., Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago 683-8504, Japan. E-mail: tani4327{at}grape.med.tottori-u.ac.jp.

Fibroblast growth factors (FGFs) exert diverse effects resulting from their interaction with cognate receptors on target cells. Our current study was designed to examine the local production and action of two specific stromal-epithelial cell mediatory factors, keratinocyte growth factor (KGF) and FGF-10, in human endometrial carcinoma cells. The RT-PCR method was used to determine gene expression of KGF, FGF-10, and KGF receptor in human endometrial carcinoma cells (HEC-1) and human endometrial stromal cells. KGF mRNAs were expressed in both of these cell types. On the other hand, FGF-10 mRNA was detected only in the endometrial stromal cells, and KGF receptor mRNA was observed in the HEC-1 cells. The novel finding of the present study is that KGF is expressed in carcinoma cells and FGF-10 is expressed in human endometrial stromal cells. The distinct phosphorylation of ERK-1 and -2 (ERK1/2), which are members of the MAPK family, was observed when HEC-1 cells were treated with KGF or FGF-10. KGF and FGF-10 could induce the prompt phosphorylation of ERK1/2 and consequently stimulate DNA synthesis. KGF and FGF-10 did not activate the phosphorylation of Akt, protein kinase C, or signal transducer and activator of transcription-3. Blocking the MAPK pathway with the specific methyl ethyl ketone 1/2 inhibitor (U0126) completely neutralized the enhancement of cell proliferation induced by KGF and FGF-10. In addition, KGF and FGF-10 activated expressions of downstream nuclear transcription factors, such as Elk-1 and c-myc, but not c-fos. These results demonstrate for the first time that KGF and FGF-10 are capable of stimulating the growth of endometrial carcinoma cells via activating MAPK pathway through autocrine/paracrine fashion.

Abbreviations: BrdU, 5-Bromo-2'-deoxyuridine; FGF, fibroblast growth factor; FGFR, FGF receptor; G3PDH, glycerol-3-phosphate dehydrogenase; HEC, human endometrial carcinoma; KGF, keratinocyte growth factor; KGFR, KGF receptor; PKC, protein kinase C; RT, reverse transcription; STAT, signal transducers and activators of transcription.




This article has been cited by other articles:


Home page
Anticancer ResHome page
H.-L. CHANG, Y. SUGIMOTO, S. LIU, L.-S. WANG, Y.-W. HUANG, W. YE, and Y. C. LIN
Keratinocyte Growth Factor (KGF) Regulates Estrogen Receptor-{alpha} (ER-{alpha}) Expression and Cell Apoptosis via Phosphatidylinositol 3-kinase (PI3K)/Akt Pathway in Human Breast Cancer Cells
Anticancer Res, August 1, 2009; 29(8): 3195 - 3205.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
H. Kashima, T. Shiozawa, T. Miyamoto, A. Suzuki, J. Uchikawa, M. Kurai, and I. Konishi
Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E
Endocr. Relat. Cancer, March 1, 2009; 16(1): 113 - 122.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. Byron, M. G. Gartside, C. L. Wellens, M. A. Mallon, J. B. Keenan, M. A. Powell, P. J. Goodfellow, and P. M. Pollock
Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation
Cancer Res., September 1, 2008; 68(17): 6902 - 6907.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Teranishi, K. Kimura, K. Kawamoto, and T. Nishida
Protection of Human Corneal Epithelial Cells from Hypoxia-Induced Disruption of Barrier Function by Keratinocyte Growth Factor
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2432 - 2437.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Takeda, T. Arao, H. Yokote, T. Komatsu, K. Yanagihara, H. Sasaki, Y. Yamada, T. Tamura, K. Fukuoka, H. Kimura, et al.
AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor
Clin. Cancer Res., May 15, 2007; 13(10): 3051 - 3057.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
N Blijlevens and S Sonis
Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis
Ann. Onc., May 1, 2007; 18(5): 817 - 826.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Zhang, J. Kosman, N. Carmean, R. Grady, and J. A. Bassuk
FGF-10 and its receptor exhibit bidirectional paracrine targeting to urothelial and smooth muscle cells in the lower urinary tract
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F481 - F494.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. Upadhyay, V. Panduri, and D. W. Kamp
Fibroblast Growth Factor-10 Prevents Asbestos-Induced Alveolar Epithelial Cell Apoptosis by a Mitogen-Activated Protein Kinase-Dependent Mechanism
Am. J. Respir. Cell Mol. Biol., March 1, 2005; 32(3): 232 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Yang, K. Cao, L. Wu, and R. Wang
Cystathionine {gamma}-Lyase Overexpression Inhibits Cell Proliferation via a H2S-dependent Modulation of ERK1/2 Phosphorylation and p21Cip/WAK-1
J. Biol. Chem., November 19, 2004; 279(47): 49199 - 49205.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society